Saxagliptin clinical trials antidiabetic drugs

BMS-477118 - BMS477118 - BMS 477118 - Onglyza - saxagliptin

Diabetes type 2

All type of patients:   pinterest powerpoint 10611,13350,13349,12907,12494,13348,12904,12495,12897,12497,13347,12901,12896,13346,12903,12905,13345,12902,12899,13340,12906,12900,13351,13352,13353

All types of patients:   pinterest powerpoint 12495,12897,12899,12900,12903,12901,12902,12906,12904,12905,12907,13340,13345,13347,13348,13349,13346,10611,13351,12494,13352,12497,13353,12896,13350

Drug naïve patients:   pinterest powerpoint 12907,12899,12897,12896

In patients inadequately controlled on standard therapy:   pinterest powerpoint 12494

Patients inadequately controlled on metformin:   pinterest powerpoint 12497,10611,12903

Patients inadequately controlled on monotherapy :   pinterest powerpoint 12903,12902,10611,12900,12905,12497

Patients inadequately controlled on TZD:   pinterest powerpoint 12905

Patients inadequately controlled with insulin:   pinterest powerpoint 12901